Response to: “Defining clinically meaningful benefit in mild-to-moderate hidradenitis suppurativa trials”
Journal of the American Academy of Dermatology · 2026-08
DOI: 10.1016/j.jaad.2026.08.062 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Bruna G O Wafae und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, Boston, Massachusetts. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Dermatology Department, Harvard Medical School, Boston, Massachusetts.
- Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Dermatology Department, Harvard Medical School, Boston, Massachusetts. Electronic…
Zitieren
APA
Wafae, B. G. O., Noel, W. C., Williams, S. A., & Porter, M. L. (2026). Response to: “Defining clinically meaningful benefit in mild-to-moderate hidradenitis suppurativa trials”. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.08.062
Vancouver
Wafae BGO, Noel WC, Williams SA, Porter ML. Response to: “Defining clinically meaningful benefit in mild-to-moderate hidradenitis suppurativa trials”. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.08.062
BibTeX
@article{Wafae2026,
author = {Wafae, Bruna G O and Noel, William C and Williams, Solomon A and Porter, Martina L},
title = {Response to: “Defining clinically meaningful benefit in mild-to-moderate hidradenitis suppurativa trials”},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.08.062}
}
EUVIMED